"Regionshospitalet Gødstrup tages løbende i brug i perioden 31. januar til 20. marts 2022. Har du brug for hjælp eller behandling, kan du besøge hospitalerne i Herning eller Holstebro indtil da. Find mere info på Hospitalsenheden Vests hjemmeside."

During the past decade, Herning Hospital conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 3 clinical trials were completed, i.e. on average, 8.6% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 2 clinical trials were completed. i.e. 8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herning Hospital" #1 sponsor was "University of Aarhus" with 11 trials, followed by "Aalborg University" with 2 trials sponsored, "Bayer" with 2 trials sponsored, "Hospitalsenheden Vest" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herning Hospital" #1 collaborator was "Aarhus University Hospital" with 7 trials as a collaborator, "Herning Hospital" with 7 trials as a collaborator, "Odense University Hospital" with 6 trials as a collaborator, "Aalborg University Hospital" with 5 trials as a collaborator and "Randers Regional Hospital" with 4 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Herning Hospital" are "Angina Pectoris" (3 trials), "Coronary Artery Disease" (3 trials), "Metastatic Colorectal Cancer" (3 trials), "Myocardial Ischemia" (3 trials) and "Atherosclerosis" (2 trials). Many other conditions were trialed in "Herning Hospital" in a lesser frequency.

Most popular intervention types in "Herning Hospital" are "Drug" (16 trials), "Other" (16 trials), "Device" (4 trials), "Behavioral" (3 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "DS5 electrical stimulator" (2 trials), "Dexamethasone" (2 trials), "Teclistamab" (2 trials) and "6% Hydroxyethyl starch 130/0.4" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herning Hospital" are 36 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Herning Hospital". undefined are not yet recruiting, 15 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Herning Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Herning Hospital, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 18 trials that are defined as “Not Applicable".

Herning Hospital has several departments that took part in Clinical trials: "Department of Medical Research, Holstebro Hospital" - 27 trials, "Holstebro Hospital, Endocrinology dept." - 3 trials, "Regionshospitalet Herning; Onkologisk afdeling" - 2 trials, "Regionshospitalet Gødstrup - Cardiology Clinic" - 2 trials, "Department of Orthopedic Surgery, Gødstrup Regional Hospital" - 2 trials, "Department of Otorhinolaryngology, Regional Hospital West Jutland" - 2 trials